Description du projet
Un système innovant de prise en charge des maladies cérébrales
Le projet EDEN2020, financé par l’UE, ambitionne de mettre au point un nouveau système de diagnostic unique et de traitement peu invasif en neurochirurgie. Le consortium s’appuiera sur l’expérience unique d’institutions de recherche et de partenaires industriels de premier plan dans le domaine de la robotique chirurgicale pour obtenir un impact clinique réel. Son objectif est de concevoir et de mettre au point une gamme de cathéters orientables pour la prise en charge de la maladie in situ par une administration robotisée et pour des périodes prolongées. Le système sera capable de détecter l’évolution de l’anatomie cérébrale en cours d’opération avec une précision inégalée et de déployer des outils optiques de diagnostic pour la prise en charge des maladies cérébrales. Le projet EDEN2020 contribuera à relever le vaste défi de l’amélioration des thérapies pour les patients atteints de cancer en permettant un traitement au sein des structures tissulaires avec une précision d’administration inégalée.
Objectif
Due to an aging population and the spiralling cost of brain disease in Europe and beyond, EDEN2020 aims to develop the gold standard for one-stop diagnosis and minimally invasive treatment in neurosurgery. Supported by a clear business case, it will exploit the unique track record of leading research institutions and key industrial players in the field of surgical robotics to overcome the current technological barriers that stand in the way of real clinical impact.
EDEN2020 will provide a step change in the modelling, planning and delivery of diagnostic sensors and therapies to the brain via flexible surgical access, with an initial focus on cancer therapy. It will engineer a family of steerable catheters for chronic disease management that can be robotically deployed and kept in situ for extended periods. The system will feature enhanced autonomy, surgeon cooperation, targeting proficiency and fault tolerance with a suite of technologies that are commensurate to the unique challenges of neurosurgery. Amongst these, the system will be able to sense and perceive intraoperative, continuously deforming, brain anatomy at unmatched accuracy, precision and update rates, and deploy a range of diagnostic optical sensors with the potential to revolutionise today’s approach to brain disease management. By modelling and predicting drug diffusion within the brain with unprecedented fidelity, EDEN2020 will contribute to the wider clinical challenge of extending and enhancing the quality of life of cancer patients – with the ability to plan therapies around delicate tissue structures and with unparalleled delivery accuracy.
EDEN2020 is strengthened by a significant industrial presence, which is embedded within the entire R&D process to enforce best practices and maximise translation and the exploitation of project outputs. As it aspires to impact the state of the art and consolidate the position of European industrial robotics, it will directly support the Europe 2020 Strategy.
Champ scientifique
- medical and health sciencesbasic medicineanatomy and morphology
- medical and health sciencesclinical medicinesurgery
- engineering and technologyelectrical engineering, electronic engineering, information engineeringelectronic engineeringsensorsoptical sensors
- medical and health sciencesbasic medicinepharmacology and pharmacypharmaceutical drugs
- medical and health sciencesclinical medicineoncology
Mots‑clés
Programme(s)
Thème(s)
Régime de financement
RIA - Research and Innovation actionCoordinateur
SW7 2AZ LONDON
Royaume-Uni